Moderna’s vaccine candidate includes three different norovirus types. “It would be great if there were some conserved regions of the norovirus protein that could be targeted, but that’s not ...

The HHS will invest $176 million in a mRNA vaccine from Moderna meant to protect against an avian influenza pandemic.

Moderna faces challenges with respiratory vaccine sales and strong competition. Click here to read an analysis of MRNA stock ...

In the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) was a top performer, from both a share-price and an ...

and mRNA-1403 (norovirus vaccine). An important candidate garnering investor attention is mRNA-4157, which is being developed in collaboration with Merck MRK. Moderna and Merck are evaluating mRNA ...

Moderna could face suspension from Britain’s pharmaceutical trade body following a string of breaches of the regulatory code. The Covid vaccine maker is due to be audited by the Prescription ...

HHS Announces Plans to Pay Moderna $176 Million for mRNA Flu Vaccine By Stephanie Brown HealthDay Reporter FRIDAY, April 25, 2025 (HealthDay News) -- On Tuesday, the U.S. Department of Health and ...

Moderna could have many products on the market and in a variety of areas. Among these, we may find a cytomegalovirus (CMV) vaccine, a personalized cancer vaccine, and a norovirus vaccine.